Substituted isoquinolines and their use as Rho-kinase inhibitors

Details for Australian Patent Application No. 2007338411 (hide)

Owner Sanofi-Aventis

Inventors Plettenburg, Oliver; Goerlitzer, Jochen; Lorenz, Katrin; Lohn, Matthias

Agent Watermark

Pub. Number AU-B-2007338411

PCT Pub. Number WO2008/077555

Priority 06026892.7 27.12.06 EP

Filing date 19 December 2007

Wipo publication date 3 July 2008

Acceptance publication date 23 August 2012

International Classifications

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 31/4725

A61P 3/00 Drugs for disorders of the metabolism

A61P 7/00 Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 25/00 Drugs for disorders of the nervous system

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 451/06 Heterocyclic compounds containing condensed hetero ring systems

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/077555 Priority application(s): WO2008/077555

23 August 2012 Application Accepted

  Published as AU-B-2007338411

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338412-Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives

2007338410-Cycloalkylamine substituted isoquinoline derivatives